NCT00038909View on ClinicalTrials.gov

Study Evaluating ReFacto in Hemophilia A

NACompletedINTERVENTIONAL

Enrollment

103

Participants

Timeline

Start Date

September 30, 1994

Primary Completion Date

May 31, 2001

Study Completion Date

May 31, 2001

Conditions

Hemophilia A

Interventions

DRUG

BDDrFVII

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00038909 - Study Evaluating ReFacto in Hemophilia A | Biotech Hunter | Biotech Hunter